Cardinal Health's Q1 2025 earnings reaffirm my buy rating due to a strengthening pharmacy business and industry tailwinds. Despite initial market overreaction to 2025 guidance, Cardinal Health's ...
In a report released on November 1, Erin Wright from Morgan Stanley maintained a Buy rating on Cardinal Health (CAH – Research Report), with a price target of $127.00. Erin Wright has given his ...
Acquisition of a majority stake in GI Alliance, the country's leading gastroenterology management services organization, to accelerate Cardinal Health's multi-specialty growth strategy Acquisition ...
Cardinal Health plans to buy two companies that will expand its diabetes and gastroenterology businesses as part of an overall strategy to grow its footprint in specialty medicine. The ...
Cardinal Health expects that costs will increase for syringes and protective equipment like gloves under Biden administration tariffs, but broader tariffs under a potential Trump return would ...
Cardinal Health is spending $3.9 billion on two acquisitions as part of what the wholesale drug and medical supply company says is part of its growth strategy and will bolster patient care.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...